• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non-Hodgkin lymphoma.

作者信息

Citrin Rebecca, Getz Kelly D, Li Yimei, Huang Yuan-Shung, Horowitz Joseph P, Seif Alix E, Fisher Brian T, Aplenc Richard

机构信息

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.

出版信息

Br J Haematol. 2019 Feb;184(4):684-688. doi: 10.1111/bjh.15159. Epub 2018 Apr 2.

DOI:10.1111/bjh.15159
PMID:29611176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6168433/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ef/6168433/e58146636f76/nihms938235f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ef/6168433/e58146636f76/nihms938235f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ef/6168433/e58146636f76/nihms938235f1.jpg

相似文献

1
The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non-Hodgkin lymphoma.急性淋巴细胞白血病和非霍奇金淋巴瘤患儿使用拉布立酶的流行病学。
Br J Haematol. 2019 Feb;184(4):684-688. doi: 10.1111/bjh.15159. Epub 2018 Apr 2.
2
Management of tumour lysis syndrome in children: what is the evidence for prophylactic rasburicase in non-hyperleucocytic leukaemia?儿童肿瘤溶解综合征的管理：非高白细胞性白血病预防性使用拉布立酶的证据是什么？
Br J Haematol. 2011 Apr;153(2):275-7. doi: 10.1111/j.1365-2141.2010.08506.x. Epub 2011 Jan 23.
3
Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin's lymphoma.用拉布立酶预防和治疗白血病及非霍奇金淋巴瘤患儿的高尿酸血症
Pathol Oncol Res. 2007;13(1):57-62. doi: 10.1007/BF02893442. Epub 2007 Mar 27.
4
Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients.重组尿酸氧化酶（拉布立酶）预防和治疗血液系统癌症患者高尿酸血症及肿瘤溶解综合征的泛欧洲多中心经济学评估
Support Care Cancer. 2003 Apr;11(4):249-57. doi: 10.1007/s00520-002-0435-3. Epub 2003 Feb 4.
5
Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies.重组尿酸氧化酶（拉布立酶）用于预防和治疗血液系统恶性肿瘤患者的肿瘤溶解综合征。
Acta Haematol. 2006;115(1-2):35-8. doi: 10.1159/000089463.
6
Management of Hyperleukocytosis in Childhood Acute Leukemia Without Leukapheresis and Rasburicase Prophylaxis.儿童急性白血病无白细胞去除术和拉布立酶预防高白细胞血症的处理。
J Pediatr Hematol Oncol. 2022 Jan 1;44(1):12-18. doi: 10.1097/MPH.0000000000002225.
7
Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.在中国，血液恶性肿瘤儿童中使用 rasburicase 进行肿瘤溶解综合征的预防和治疗相对于标准治疗的成本效果分析。
J Med Econ. 2019 Aug;22(8):742-750. doi: 10.1080/13696998.2019.1603155. Epub 2019 Apr 30.
8
Treatment of impending tumor lysis with single-dose rasburicase.单剂量重组尿酸氧化酶治疗即将发生的肿瘤溶解综合征。
Ann Pharmacother. 2003 Nov;37(11):1614-7. doi: 10.1345/aph.1D111.
9
Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden.单剂量拉布立酶是一种预防高肿瘤负荷儿童肿瘤溶解综合征的临床有效且具有药物经济学价值的方法。
Br J Haematol. 2018 Jun;181(5):696-698. doi: 10.1111/bjh.14689. Epub 2017 May 8.
10
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma.重组尿酸氧化酶用于预防或治疗白血病或淋巴瘤患者的高尿酸血症。
J Clin Oncol. 2001 Feb 1;19(3):697-704. doi: 10.1200/JCO.2001.19.3.697.

引用本文的文献

1
Elevated serum uric acid is associated with the risk of advanced staging and vascular involvement in patients with hepatoblastoma: a 14-year retrospective study.血清尿酸升高与肝母细胞瘤患者的晚期分期及血管受累风险相关：一项14年的回顾性研究
Front Oncol. 2023 Apr 14;13:1144349. doi: 10.3389/fonc.2023.1144349. eCollection 2023.
2
Evaluation of the safety and efficacy of low-dose rasburicase in critically ill children with haematological malignancies.评估低剂量拉布立酶在血液恶性肿瘤危重症患儿中的安全性和疗效。
Int J Clin Pharm. 2020 Dec;42(6):1440-1446. doi: 10.1007/s11096-020-01144-8. Epub 2020 Sep 24.

本文引用的文献

1
Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database.在儿科健康信息系统数据库中创建一个儿科成熟B细胞非霍奇金淋巴瘤队列。
PLoS One. 2017 Oct 23;12(10):e0186960. doi: 10.1371/journal.pone.0186960. eCollection 2017.
2
Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States.美国接受重症监护的儿科急性髓细胞白血病患者的结局。
Pediatr Crit Care Med. 2014 Feb;15(2):112-20. doi: 10.1097/PCC.0000000000000042.
3
Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia.
医院对急性淋巴细胞白血病患儿抗生素使用的差异。
Leuk Lymphoma. 2013 Aug;54(8):1633-9. doi: 10.3109/10428194.2012.750722. Epub 2012 Dec 26.
4
Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems database.1999 年和 2009 年使用地塞米松预防治疗儿童急性淋巴细胞白血病或髓性白血病：来自儿科健康信息系统数据库的全国患儿队列分析。
Pediatr Blood Cancer. 2013 Apr;60(4):616-20. doi: 10.1002/pbc.24270. Epub 2012 Sep 4.
5
Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data.从医疗保健管理数据中建立了一个由 8733 名患有新诊断急性淋巴细胞白血病的美国独立儿童医院住院患儿组成的 11 年队列。
Med Care. 2014 Jan;52(1):e1-6. doi: 10.1097/MLR.0b013e31824deff9.
6
The tumor lysis syndrome.肿瘤溶解综合征
N Engl J Med. 2011 May 12;364(19):1844-54. doi: 10.1056/NEJMra0904569.
7
Management of tumour lysis syndrome in children: what is the evidence for prophylactic rasburicase in non-hyperleucocytic leukaemia?儿童肿瘤溶解综合征的管理：非高白细胞性白血病预防性使用拉布立酶的证据是什么？
Br J Haematol. 2011 Apr;153(2):275-7. doi: 10.1111/j.1365-2141.2010.08506.x. Epub 2011 Jan 23.
8
Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.恶性肿瘤成人和儿童肿瘤溶解综合征（TLS）风险评估和预防推荐：专家 TLS 小组共识。
Br J Haematol. 2010 May;149(4):578-86. doi: 10.1111/j.1365-2141.2010.08143.x. Epub 2010 Mar 16.
9
SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey.法国儿童和青少年癌症与白血病防治协会（SFCE）关于使用拉布立酶治疗肿瘤溶解综合征（TLS）的建议：一项观察性调查。
J Pediatr Hematol Oncol. 2008 Apr;30(4):267-71. doi: 10.1097/MPH.0b013e318162bd41.